RDY 56.01 Dr. Reddy's Laboratories Ltd $RDY Hit a 52 week

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
RDY 56.01 Dr. Reddy's Laboratories Ltd $RDY Hit a 52 week high of 56.31 Closing the day 09:44 at 56.01 +0.06 +0.11% With a day low of 55.80 and a total volume of 22,779.

RDY Recent Posts: http://investorshangout.com/Dr-Reddys-Laborat...RDY-52499/

RDY Dr. Reddy's Laboratories Ltd Recent Headline News

Dr. Reddy's cleared for generic Valcyte
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 6:34AM CST

ENDP: 67.77 (-0.49), RDY: 56.57 (+0.62)

Dr. Reddy's (RDY) Q2 Earnings Fall, Revenues Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 4:20PM CDT
Dr. Reddy's Laboratories (RDY) reported second-quarter fiscal 2015 earnings per American Depositary Share (ADS) of 54 cents, down 17% from the year-ago quarter.
MNK: 92.98 (-0.73), ACT: 241.03 (-2.60), MYL: 53.79 (+0.28), RDY: 56.57 (+0.62)

Dr. Reddy's Laboratories (RDY) Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 12:50AM CDT

RDY: 56.57 (+0.62)

Dr. Reddys ups revenues 7% in FQ2
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 12:43PM CDT

RDY: 56.57 (+0.62)

Dr. Reddy's FQ2 EPS of $0.54
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 5:55AM CDT

RDY: 56.57 (+0.62)

Dr. Reddy's Q2 and H1 FY15 Financial Results
Business Wire - Wed Oct 29, 5:41AM CDT
--Q2 FY15 EBITDA at Rs. 8.7 billion (24% of the revenues)
RDY: 56.57 (+0.62)

Dr. Reddy's Announces the Launch of Sirolimus Tablets, 1 mg and 2 mg
Business Wire - Tue Oct 28, 12:24PM CDT
Dr. Reddy's Laboratories (NYSE: RDY) announced today that it has launched Sirolimus Tablets 1 mg and 2 mg, a therapeutic equivalent generic version of RAPAMUNE(R) (Sirolimus) tablets in the US market on October 27, 2014, following the approval by the United States Food & Drug Administration (USFDA).
RDY: 56.57 (+0.62)

Dr. Reddy's reports on October 29
Seeking Alpha - at Seeking Alpha - Fri Oct 17, 6:09AM CDT

RDY: 56.57 (+0.62)

Dr. Reddy's to Release Q2 FY15 Results on October 29, 2014
Business Wire - Fri Oct 17, 4:38AM CDT
Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the Second Quarter ended September 30, 2014 on Wednesday, October 29, 2014 after the Board Meeting. The results will be available on the Company's website www.drreddys.com.
RDY: 56.57 (+0.62)

Sucampo Enters into Settlement Agreement for Amitiza - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 4:50PM CDT
Sucampo Pharmaceuticals, Inc. (SCMP) has entered into a settlement agreement with Anchen and Par regarding a patent litigation related to Sucampo's Amitiza.
LCI: 49.53 (-0.48), SCMP: 10.35 (+0.65), RDY: 56.57 (+0.62)

Dr Reddys Laboratories Has Returned 20.3% Since SmarTrend Recommendation (RDY)
Comtex SmarTrend(R) - Wed Oct 08, 4:57PM CDT
SmarTrend identified an Uptrend for Dr Reddys Laboratories (NYSE:RDY) on June 26th, 2014 at $41.48. In approximately 3 months, Dr Reddys Laboratories has returned 20.35% as of today's recent price of $49.92.
RDY: 56.57 (+0.62)

Dr Reddys Laboratories Shares Up 26.0% Since SmarTrend's Buy Recommendation (RDY)
Comtex SmarTrend(R) - Wed Oct 01, 11:03AM CDT
SmarTrend identified an Uptrend for Dr Reddys Laboratories (NYSE:RDY) on June 26th, 2014 at $41.48. In approximately 3 months, Dr Reddys Laboratories has returned 25.96% as of today's recent price of $52.25.
RDY: 56.57 (+0.62)

Dr. Reddy's (RDY) Generic Xopenex Launched in the US - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Sep 25, 5:19PM CDT
Dr. Reddy's Laboratories Ltd. (RDY) has launched its generic version of Sunovion Pharmaceuticals Inc.???s Xopenex in the U.S.
SUPN: 8.47 (+0.56), MYL: 53.79 (+0.28), TEVA: 58.40 (+0.21), RDY: 56.57 (+0.62)

Uptrend Call Working As Dr Reddys Laboratories Stock Rises 26.6% (RDY)
Comtex SmarTrend(R) - Wed Sep 24, 9:40AM CDT
SmarTrend identified an Uptrend for Dr Reddys Laboratories (NYSE:RDY) on June 26th, 2014 at $41.48. In approximately 3 months, Dr Reddys Laboratories has returned 26.59% as of today's recent price of $52.51.
RDY: 56.57 (+0.62)

Dr. Reddy's unveils US FDA approved Levalbuterol Inhalation Solution, USP for oral inhalation only
M2 - Wed Sep 24, 7:03AM CDT
Pharmaceutical company Dr. Reddy's Laboratories (NYSE:RDY) reported on Wednesday the market availability of Levalbuterol Inhalation Solution, USP 0.31 mg /3 ml, 0.63 mg /3 ml, 1.25 mg / 3 ml Unit-Dose Vials in the US.
RDY: 56.57 (+0.62)

Dr. Reddy's Announces the Launch of LEVALBUTEROL INHALATION SOLUTION, USP
Business Wire - Wed Sep 24, 2:27AM CDT
Dr. Reddy's Laboratories (NYSE: RDY) announced today that it has launched Levalbuterol Inhalation Solution, USP 0.31 mg /3 mL, 0.63 mg /3 mL, 1.25 mg / 3 mL Unit-Dose Vials, a therapeutic equivalent generic version of XOPENEX(R) (levalbuterol hydrochloride) inhalation solution in the US market on September 23, 2014, approved by the United States Food & Drug Administration (USFDA).
RDY: 56.57 (+0.62)

17.9% Return Seen to Date on SmarTrend Dr Reddys Laboratories Call (RDY)
Comtex SmarTrend(R) - Tue Sep 09, 4:52PM CDT
SmarTrend identified an Uptrend for Dr Reddys Laboratories (NYSE:RDY) on June 26th, 2014 at $41.48. In approximately 3 months, Dr Reddys Laboratories has returned 17.91% as of today's recent price of $48.91.
RDY: 56.57 (+0.62)

Uptrend Call Working As Dr Reddys Laboratories Stock Rises 18.5% (RDY)
Comtex SmarTrend(R) - Tue Sep 02, 10:58AM CDT
SmarTrend identified an Uptrend for Dr Reddys Laboratories (NYSE:RDY) on June 26th, 2014 at $41.48. In approximately 2 months, Dr Reddys Laboratories has returned 18.47% as of today's recent price of $49.14.
RDY: 56.57 (+0.62)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Syra Health Joins CMS ACCESS Model for Scalable Growth

Updated Category News Views 2

Syra Health Secures Spot in CMS ACCESS Model Every once in a while, a company gets a nod that could redefine its trajectory, and today it’s Syra Health’s turn at bat. Teaming up with HealthSync, they’ve clinched a position in the coveted CMS ACCESS model—a move not just about snagging headlines but potentially securing a golden ticket to a robust revenue stream...

Continue Reading
AWOL Vision's LuxVision: Pushing Home Cinema Limits

Updated Category News Views 1

AWOL Vision Leaps into the Future at IFA 2026 You'll never look at home entertainment the same way. AWOL Vision's grand entrance at IFA 2026 in Berlin isn't just about a shiny new gadget; it's a full-blown mission to redefine what your living room can do. With its debut of the LuxVision projector, they're not just holding a torch—they're carrying a flamethrower into the...

Continue Reading
Veteran Suicide Prevention: The Urgency Behind CVN's Push

Updated Category News Views 3

Veteran suicide is a crisis staring us square in the face, with rates 60% higher than the general population. It's a grim reminder that the mental toll on those who've served is a deep chasm hard to bridge. Cohen Veterans Network (CVN) is stepping up to the plate with a new campaign dubbed 'Ask Anyway: Conversations to Save a Life'. This isn't just any awareness...

Continue Reading
Baystate Noble Plans Major ED Expansion for Future Needs

Updated Category News Views 2

A Trusted Name in Healthcare Steps Up When a healthcare player like Baystate Health decides to jump into the deep end with an expansion project, you know they're not just doodling on napkins. With a legacy stretching back to 1883, Baystate Health, anchored deeply in western New England, isn't just expanding for fun—it's a move to cement its position as a crucial...

Continue Reading
TPx Pivots Post-Bankruptcy, Rebuilding for New Growth

Updated Category News Views 15

TPx Rebounds with Stronger Foundation Folks, TPx just got itself a fresh pair of legs to stand on. Emerging from the labyrinth of Chapter 11 bankruptcy, TPx has managed to shave off a cumbersome load of debt and cement a pathway to long-term success. A court nod from the U.S. Bankruptcy Court for the Southern District of Texas confirmed their reorganization plan. It's a...

Continue Reading
Mitrade EU Enhances Investor Safety with New Insurance

Updated Category News Views 3

Mitrade's New Insurance: A Safety Net? Mitrade EU is amping up its game with some fresh insurance perks that catch the eye. They're slapping on some extra insolvency protection for clients trading under their CySEC license. Now that sounds like a financial shield anyone would want. Basically, they're adding another layer to the basic regulatory protections, and without...

Continue Reading
Finzly Launches AI Security Layer Amid Rising Threats

Updated Category News Views 3

Bank Security in the Age of AI You'd think banks, of all places, were impenetrable fortresses. But these days, they're more like digital targets. With AI-driven attacks becoming as common as morning coffee, Finzly's introducing Assure, an AI-powered security and assurance layer. It's about as timely as ever, given the 89% spike in AI-enabled attacks seen last year. When...

Continue Reading
MemoryDriver Relaunches with Navigation Challenge

Updated Category News Views 2

MemoryDriver's Relight: A Blazing New Course in Brain Health Look at this: Evon Medics is back with a bang, and they're handing us more than just another mind-numbing app update. On September 15, they're flipping the switch on MemoryDriver, their revamped brain-training gig, with a national 'Beat the Clock' Challenge. It’s up for grabs, totally free, and full of...

Continue Reading
Flotek Faces Lawsuit: Investors Urged to Act Fast

Updated Category News Views 3

Flotek's Current Storm: Gather Your Wits, Shareholders If you've staked your hard-earned cash into Flotek Industries, Inc. (FTK), it's high time to buckle up. Those court-blaring sirens aren’t a drill: we're talking class-action territory, people. The Law Offices of Howard G. Smith sound the alarm, calling on investors who’ve had their financial feathers singed to...

Continue Reading
Little Sunshine's Opens New School in Peoria, AZ

Updated Category News Views 0

Betting On Early Childhood Education Little Sunshine's Playhouse breaks ground on a fresh hub of learning in Peoria, Arizona, and this is no small playdate. It's the dawn of another preschool institution aiming to mold the early years of countless kiddos. The gears turning behind this development are impressive by themselves, but it's what it means for Peoria's families...

Continue Reading

Top 5 Most Recently Viewed Articles

Join Elanders AB's Annual General Meeting for Shareholders

Updated Category News Views 143

Invitation to the Annual General Meeting of Elanders AB Shareholders of Elanders AB (publ) are warmly invited to participate in the upcoming Annual General Meeting, scheduled for a Wednesday in the spring. This significant event is set to take place at the Södra Porten Conference Center, located at Flöjelbergsgatan 1 C. An opportunity for networking and fellowship is...

Continue Reading
The Journey of Stairhopper Movers LLC: A New Perspective

Updated Category News Views 181

Unveiling the Success Story of Stairhopper Movers LLC The upcoming episode of "All Access with Andy Garcia" is an exciting opportunity for viewers to learn about Stairhopper Movers LLC. This feature showcases the company’s journey and its focus on reliability and professionalism within the relocation industry. Highlighting essential factors that contribute to a...

Continue Reading
Kestra Medical Technologies Moves Forward with Major Share Offering

Updated Category News Views 157

Kestra Medical Technologies Announces Public Offering Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a pioneer in wearable medical devices and digital healthcare solutions, has made headlines recently with its announcement of an underwritten public offering aimed at raising capital for its initiatives. This offering involves 5,500,000 common shares and is a strategic...

Continue Reading
Empowering Girls: A Global Call to Action from Leaders

Updated Category News Views 271

Empowering Young Women for a Brighter Future Recently, a significant gathering took place that turned the spotlight on an essential part of our global community: young women. Activists from the "What Girls Want" campaign boldly urged world leaders to recognize and prioritize the needs and dreams of girls in global discussions that will shape their futures. This pressing...

Continue Reading
Subway's Special Offer: 2 Six-Inch Subs for Just $6

Updated Category News Views 113

Subway Launches Unique Offer for a Special Date The excitement is in the air as Subway unveils a remarkable offer that’s bound to please everyone. On a unique date, customers can enjoy two six-inch subs for only $6. This deal is available for a limited time, so fans should mark their calendars. The event is happening on the date 2/6/26, a momentous occasion that won't...

Continue Reading